Inogen to Present at Upcoming Investor Conferences in November 2023
Inogen Expands Its Respiratory Product Portfolio with Acquisition of Physio-Assist
Inogen, Inc. Home
Latest Events
Nov 7, 2023 • 5:00pm ESTInogen 2023 Third Quarter Financial Results
Latest Financial Results
Q3 2023
Quarter Ended Sep 30, 2023
$84.0M
Total third quarter revenue of $84.0 represented a sequential improvement from Q2 revenue of $83.6 million
(10.4%)
Total operating expense, excluding one-time costs, declined 10.4% year-over-year
8.7%
Rental revenue grew 8.7% year-over-year
For complete information regarding our financials, see our periodic filings
Annual Reports & Proxy Statements
Inogen Stockholder Engagement Presentation 2023
Inogen 2023 Annual Meeting of Shareholders
May 31, 2023 • 10:00am PDT
Sign up for Email Alerts
Give Me AlertsStock Information
Inogen, Inc.
About Inogen
Inogen, Inc. (Nasdaq: INGN) is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its oxygen therapy products widely available allowing patients the chance to remain ambulatory while managing the impact of their disease.
View Company Profile2022 Revenue Breakdown
2021 Revenue Breakdown
Products
Inogen One G5®
- 6 flow settings
- 4.7 pounds
- Battery life up to 13 hours
- Technology clinically validated for 24/7 use
- Meets FAA requirements
Inogen One G4®
- 3 flow settings
- 2.8 pounds
- Battery life up to 5 hours
- Meets FAA requirements
- Technology clinically validated for 24/7 use
Inogen At Home®
- 5 liters per minute, continuous flow
- Only 18 pounds
- Extremely quiet
- Energy-efficient
- Only 100W on Flow Setting 2